HealthcareThe Importance of Operational Excellence in Central Imaging Services

Introduction

As multi-center, global clinical trials are becoming the standard, the need for consistent protocol adherence, harmonious data collection, and effective communication across sites is affecting all areas of research design. Imaging data in particular plays an instrumental role in determining clinical trial endpoints, including safety and efficacy, variability, inconsistency, and operational inefficiency can undermine the value of research findings if imaging processes are not centralized.

Central imaging services have emerged as a strategic solution for clinical trial sponsors, promoting the standardized analysis of medical imaging data within clinical trials, ensuring consistent data sets, reduced variability, and improved imaging accuracy throughout. This article will consider how central imaging services can enhance the conduct of your clinical trial, facilitating global scalability through operational excellence, with clear and actionable considerations for sponsors, research CROs, and biotechs around the world.

Global scalability and collaboration

With the World Health Organization ensuring a global commitment from Member States to collaborative clinical trials, global, multi-stakeholder research studies are providing the opportunity to generate high-quality evidence for healthcare decision-making, with data becoming more generalizable than ever before. Extending patient enrolment across regions and healthcare systems generates data reflective of real-world patient populations, an approach which is widely encouraged by academic institutes, regulatory bodies, and research networks. By including multiple sites and participants across different locations and countries, trials can capture a much wider patient demographic, including valuable data on comorbidities and standards of care, which can provide much more robust insight into a specific condition or intervention, ensuring evidence generation is equitable and sustainable.

While global scalability has the potential to advance research through collaboration, it requires a robust central imaging infrastructure, one which is capable of processing imaging data across sites, countries, diverse cultures, and heterogeneous regulatory jurisdictions. Imaging data sets, especially in this context, are large, sensitive, and subject to regulatory scrutiny, with challenges occurring through variable site capacity, patient recruitment, cultural and ethical diversity, and logistical constraints. Differences in scanner hardware, acquisition protocols, site expertise, and local regulation could throw the quality and overall integrity of clinical trial results, something which can be compounded in a global context, ultimately reducing the reproducibility and interpretability of study data.

“The complexity is amplified in multi-country studies, where operational leaders must harmonize regulatory submissions, coordinate multi-stakeholder interactions, and adapt to variable healthcare infrastructures while maintaining scientific rigor and ethical compliance.” -Ezeanochie et al, 2023.

Ensuring operational excellence in central imaging services is non-negotiable. Sponsors are increasingly relying on central imaging service providers to combine the technical standardization needed to produce high-quality imaging data with robust operational frameworks.

When well executed, central imaging services ensure:

• Consistent protocol adherence across global sites
• Reduced inter- and intra-related variability
• Harmonious data acquisition and analysis
• Improved regulatory confidence in imaging endpoints

Operational excellence in central imaging

Operational excellence in central imaging services goes far beyond efficiency, being at the core of all quality imaging outcomes and fostering integration across global teams. Operational excellence reflects a commitment to quality, compliance, and continuous improvement across every stage of the imaging lifecycle, with cross–functional coordination, risk-based monitoring, digital trial innovations, and data-driven decision-making frameworks enhancing trial efficiency and ensuring patient-centric outcomes.

In practice, this can look like:

• Standardized imaging protocols
• Scanner calibration and routine quality checks
• Centralized quality views and audit trails
• Experienced, centralized image interpretation
• Secure, scalable global data infrastructure

Why does this matter to sponsors? These elements reflect a commitment to the integrity of clinical trial imaging data, which is looked upon favorably by regulatory bodies, and can enhance the overall success of clinical drug development.

Perceptive Imaging

Perceptive Imaging, a global leader in centralized imaging services for clinical trials, has dedicated nearly 30 years to offering best-in-class clinical trial imaging services and solutions. Placing operational excellence as a core value pillar, Perceptive ensures reliable, compliant, and high-quality imaging data throughout all clinical trials andacross all therapeutic areas. Perceptive effectively balances competing global priorities, ensures supply chain resilience, and leverages advanced technologies to facilitate operational excellence, proactively problem-solving to meet the needs of evolving global imaging requirements.

Operational excellence in central imaging services enables faster, more confident data analyses, supports the scalability of your drug development program, and improves collaboration between global sites and stakeholders. “We pursue the highest standards in everything we do,” explains Perceptive. “Through a focus on accuracy, consistency, and value, we work to mitigate risk, secure regulatory compliance, and accelerate the development of new life-changing treatments.”

To de-risk your global clinical trial imaging data, reach out today, and one of our solution experts will be in touch to learn about your central imaging needs.

Resources

World Health Organisation. https://www.who.int/news/item/07-10-2025-who-launches-the-global-clinical-trials-forum

Gyanshauryam, International Scientific Refereed Research Journal. Ezeanochie et al. Operational Leadership in Managing Complex, Multi-Country Oncology Clinical Trials. https://gisrrj.com/paper/GISRRJ236329.pdf